Current Issues in Ventilator-Associated Pneumonia

Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Infections in critically ill patients account for a major proportion of the mortality, morbidity, and cost associated with their care. Infection rate in critically ill patients are about 40% and may be 50–60% in those remaining in the intensive care unit (ICU) for more then 5 days.1,2 Pneumonia acquired in the ICU (after 48 h intuba tion) ranges from 10% to 65%,3,4 and respiratory infections account for 30–60% of all infections acquired in the ICU.5,6 Mortality rates of ventilator-associated pneumonia (VAP) have been very high (30–70%) and may account for 15% of all deaths in the ICU. 7–9 When controlled for severity of underlying disease and other factors the attributable mortality of VAP range from 0% to 50% absolute increase, and prolonged length of ICU stay (range 5–13 days).10 In a recent review of the clinical and economic consequences of VAP from analysis of studies published after 1990, the findings were: 10–20% of ICU-ventilated patients will develop VAP, and are twice as likely to die compared to patients without VAP, with 6 extra days in the ICU and an additional US$10019 hospital cost per case.11

Empiric broad-spectrum antimicrobials in the ICU for presumed pneumonia has contributed substantially to the worldwide increase in antibiotic-resistant bacteria in hospitals. This has compounded the problem of increasing morbidity, mortality, and cost because of the challenge posed by these difficult-to-treat microorganisms, particularly the use of expensive drugs and need for isolation.


Intensive Care Unit Patient Nosocomial Pneumonia Noninvasive Positive Pressure Ventilation Quantitative Culture Stress Ulcer Prophylaxis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bueno-Cavanillas, A., Delgado- Rodriguez, M., Lopez-Luque, A., Schaffinocano, S., Galvez-Vargas, R., (1994), Influence of nosocomial infection on mortality rate in intensive care unit. Unit Core Med. 22:55–60.Google Scholar
  2. 2.
    Ginou, E., Stephen, F., Novara, A., Safor, M., Fagon, J.Y., (1998), Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am. J. Respir. Crit. Care. Med. 157:1151–1158.Google Scholar
  3. 3.
    Rello, J., Quintana, E., Ausina, V., Castella, J., Luquin, M., Net., A., Prats, G., (1991), Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100:439–444.PubMedGoogle Scholar
  4. 4.
    Fagon, J.Y., Chastre, J., Vuagnat, A., Trouillet, J.L., Novora, A., Gilbert, C., (1996), Nosoco-mial pneumonia and mortality among patients in intensive care unit. JAMA 275:866–869.PubMedGoogle Scholar
  5. 5.
    Vincent, J.L., Bihari, D.J., Suter, P.M., Bruining, H.A., White, J., Nicholas-Chanoin, M.H., Wolff, M., Spencer, R.C., Hemmer, M., (1995), The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.JAMA 274:639–644.PubMedGoogle Scholar
  6. 6.
    Potgieter, P.D., Linton, D.M., Oliver, S., Forder, A.N., (1987), Nosocomial infections in a respiratory intensive care unit. Crit. Care. Med. 15:495–498.PubMedGoogle Scholar
  7. 7.
    Chastre, J., Fagon, J.Y., Trouillet, J.L., (1995) Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin. Infect. Dis. 21(Suppl. 3):S226–S237PubMedGoogle Scholar
  8. 8.
    Fagon, J.Y., Chastre, J., Hance, A.J., Montravers, P., Novara, A., Gilbert, C., (1993), Nosoco-mial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 94:281–288.PubMedGoogle Scholar
  9. 9.
    Crouch, B.S., Wunderink, R.G., Jones, C.B., Leeper, K.V.J., (1996) Ventilator associated pneumonia due to Pseudomonas aeruginosa. Chest 109:1019–1029.Google Scholar
  10. 10.
    Dodek, P., Keenan, S., Cook, D., Heyland, D., Jacka, M., Hand, L., Muscedere, J., Foster, D., Mehta, N., Hall, R., Bun-Buisson, C., For the Canadian Critical Care Trials Group and The Canadian Critical Care Society, (2004), Evidence based clinical practice guideline for the prevention of ventilator associated pneumonia. Ann. Intern. Med 141:305–313.PubMedGoogle Scholar
  11. 11.
    Safdar, N., Dezfulian, C., Collard, H.R., Saint, S., (2005), Clinical and economic consequences of ventilator associated pneumonia: a systematic review. Crit. Care. Med. 33:2184–2193.PubMedGoogle Scholar
  12. 12.
    Fabregas, N., Ewig, S., Torres, A., El-Ebiary, M., Ranirez, J., dela Bellacusa, J.P., Bauer, T., Cabello, H., (1999), Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873.PubMedCrossRefGoogle Scholar
  13. 13.
    Torres, A., Ewig, S., (2004), Diagnosing ventilator associated pneumonia. N. Engl. J. Med. 350:433–435.PubMedGoogle Scholar
  14. 14.
    Pugin, J., Anckenthaler, R., Mili, N., Janssens, J.P., Lew, P.D., Suter, P.M, (1991), Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic “blind” bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 143:1121–1129.PubMedGoogle Scholar
  15. 15.
    Richards, M.J., Edwards, J.R., Culver, D.H., David, H., Gaynes, R., (1999), Nosocomial infection in medical intensive care unit in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887–892.PubMedGoogle Scholar
  16. 16.
    Carlet, J., Ben Ali, A., Chalfine, A., (2004), Epidemiology and control of antibiotic resistance in the intensive care unit. Curr. Opin. Infect. Dis. 17:309–316.PubMedGoogle Scholar
  17. 17.
    Gaynes, R., Edwards, J.R., (2005), Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 41:848–854.PubMedGoogle Scholar
  18. 18.
    Marquette, C., Georges, H., Wallet, F., Ramon, P., Saulnier, F., Neviere, R., Mathieu, D., Rime, A., Tonnel, A.B., (1993), Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Am. Rev. Respir. Dis. 148:138–144.PubMedGoogle Scholar
  19. 19.
    el-Ebiary, M., Torre, A., Gonzales, J., dela Bellacasa, J.P., Garcia, C., Jimenez de Anta, M.T., Ferrer, M., Rodriguez-Roisin, R., (1993), Quantitative cultures of endobronchial aspirates for the diagnosing of ventilator associated pneumonia. Am. Rev. Respir. Dis. 148:1552–1557.PubMedGoogle Scholar
  20. 20.
    Mondi, M.M., Chang, M.C., Bowton, C.L., Kiglo, P.D., Meredith, J.W., Miller, P.R., (2005), Prospective comparison of bronchial-alveolar lavage quantitative deep –tracheal aspirate in the diagnosis of ventilator associated pneumonia. J. Trauma-Injury Infect. Crit. Care. 59:891–895.Google Scholar
  21. 21.
    Borderon, E., Leprince, A., Guevelier, C., Borderon, J., (1981), Valeirs des examenes barteriologiques des secretions tracheales. Rev. Fr. Mal. Resp. 9:229–239.Google Scholar
  22. 22.
    Meduri, G.U., Chastre, J., (1992), The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 102(Suppl. 1):5575–5645.Google Scholar
  23. 23.
    Meduri, G.U., Beals, D.H., Maijub, A.G., Baselski, V.L., (1991), Protested bronchoalveolar lavage: a new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am. Rev. Respir. Dis. 143:855–864.PubMedGoogle Scholar
  24. 24.
    Chastre, J., Fagon, J.Y., Soler, P., Bornet, M., Domart, Y., Trouillet, J.L., Gibert, C., Hance, A. J., (1988), Diagnosis of nosocomial bacterial pneumonia in intubated paitents undergoing ventilation: comparison of the usefulness of bronchoalveolor lavage and the protected specimen brush. Am. J. Med. 85:499–506.PubMedCrossRefGoogle Scholar
  25. 25.
    Chastre, J., Fagon, J.Y., Soler, P., Domart, Y., Pierre, J., Dombret, M.C., Gibert, C., Hance, A. J., (1989), Quantitation of BAL cells containing intracellular bacteria rapidly identifies ventilated patients with nosocomial pneumonia. Chest 95(Suppl.):1905–1925.Google Scholar
  26. 26.
    Jourdain, B., Jolly-Guillou, M.L., Dombret, M.C., Calvat, S., Trouillet, J.L., Gibert, C., Chastre, J., (1993), Usefullness of quantitative cultures of BAL fluid for diagnosing nosoco-mial pneumonia in ventilated patients. Chest 103:1017–1022.Google Scholar
  27. 27.
    de Jaeger, A., Litalien, C., Lacroix, J., Guertin, M.C., Infante-Rivard, C., (1999), Protected specimen brush or bronchoalveolar lavage to diagnose nosocomial pneumonia in ventilated adults: a meta-analysis, Crit. Care Med. 27:2548–2560.Google Scholar
  28. 28.
    Brun-Buisson, C., Fartoukh, M., Lechapt, E., Honore, S., Zahar, J.R., Cerf, C., Maitre, B., (2005), Contribution of blinded, protected quantitative specimens to the diagnosis and therapeutic management of ventilator associated pneumonia. Chest 128:533–544.PubMedGoogle Scholar
  29. 29.
    Mentec, H., May-Michelangeli, L., Rabbat, A., Varon, E., Le Turdu, F., Bleichner, G., (2004), Blind and bronchoscopic sampling methods on suspected ventilator associated pneumonia. A multicentre prospective study. Inten. Care Med. 30:1319–1326.Google Scholar
  30. 30.
    Wood, A.Y., Dovit, A.J. 2nd, Ciraulo, D.L., Ays, N.W., Richart, O.M., Maxwell, R.A., Baxer, D.E., (2003), A prospective assessment of diagnostic efficacy of blind protective bronchial brushings compared to bronchoscope-assisted lavage, bronchoscope-directed brushing, and blind and endotracheal aspirates in ventilator associated pneumonia. J. Trauma-Injury Infect. Crit. Care: 55:825–834.Google Scholar
  31. 31.
    Butler, K.L., Best, I.M., Oster, R.A., Katon-Benitez I., Lyn Weaver, W., Bumpers, H.L., (2004), Is bilateral protected specimen brush sampling necessary for the accurate diagnosis of ventilation-associated pneumonia. J. Trauma-Injury Infect. Crit. Care: 57:316–322.Google Scholar
  32. 32.
    Michaud, S., Suzuki, S., Harlarth, S., (2002), Effect of design-related bias in studies of diagnostic tests for ventilated pneumonia. Am. J. Respir. Crit. Care Med. 166:1320–1325.PubMedGoogle Scholar
  33. 33.
    Chastre, J., Viau, F., Brum, P., Pierre, J., Dauge, M.C., Bouchama, A., Akesbi, A., Gibert, C., (1984), Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am. Rev. Respir. Dis. 130:924–929.PubMedGoogle Scholar
  34. 34.
    Rouby, J.J., De Lassale, E.M., Poete, P., Nicolas, M.H., Bodin, L., Jarlier, V., Le Carpentier, Y., Grosset, J., Viars, P., (1992), Nosocomial bronchopneumonia in the critically ill. Histo-logic and bacteriologic aspects. Am. Rev. Respir. Dis. 146:1059–1066.PubMedGoogle Scholar
  35. 35.
    Torres, A., el-Ebiary, M., Padro, L., Gonzalez, J., De La Bellacasa, J.P., Ramirez, J., Xaubet, A., Ferrer, M., Rodriguez-Roisin, R., (1994), Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 149:324–331.PubMedGoogle Scholar
  36. 36.
    Chastre, J., Fagon, J.Y., Barnet-Lecso, M., Calvat, S., Dombret, M.C., Al Khani, R., Basset, f., Gibert, C., (1995), Evaluation of broncoscopic techniques for the diagnosis of nosocomial pneumonia. Am. J. Respir. Crit. Care Med. 152:231–240.PubMedGoogle Scholar
  37. 37.
    Papazian, L., Thomas, P., Garbe, L., Guignon, I., Thirion, X., Charrel, J., Bollet, C., Fuentes, P., Gouin, F., (1995), Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 152:1982–1991.PubMedGoogle Scholar
  38. 38.
    Marquette, C.H., Copin, M. C., Wallet, F., Neviere, R., Saulnier, F., Mathieu, D., Dirocher, A., Ramon, P., Tonnel, A.B., (1995), Diagnostic tests for pneumonia in ventilated patients: Prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am. J. Respir. Crit. Care Med. 151:1878–1888.PubMedGoogle Scholar
  39. 39.
    Kirtland, S.H., Corley, D.E., Winterbauer, R.H., Springmeyer, S.C., Casey, K.R., Hampson, N.B., Dreis, D.E., (1997), The diagnosis of ventilator associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 112:445–457.PubMedGoogle Scholar
  40. 40.
    Bregeon, F., Papazian, L., Thomas, P., Corret, V., Garbe, L., Saux, P., Drancourt, M., Auffray, J.P., (2000), Diagnostic accuracy of protected catheter sampling in ventilator associated bacterial pneumonia. Eur. Respir. J. 16:969–975.PubMedGoogle Scholar
  41. 41.
    Torres, A., Fabregas, N., Ewig, S., de la Bellacasa, J.P., Bauer, T.T., Ramirez, J., (2000), Sampling methods for ventilator associated pneumonia: validation using different histologic and microbiological references. Crit. Care Med. 28:2799–2804.PubMedGoogle Scholar
  42. 42.
    Balthazor, A.B., Von Nowakonski, A., De Copitani, E.M., Bottini, P.V., Terzi, R.G.G, Araujo, S., (2001), Diagnostic investigation of ventilator associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Brazilian J. Med. Biolog. Res. 34:993–1001.Google Scholar
  43. 43.
    Moser, K.M., Maurer, J., Jassy, L., Kremsdorf., R., Konopka, R., Share, D., Hurrell, J.H., (1982), Sensitivity, specificity, and risk of diagnostic procedures in a canine model of Sreptococusl Pneumoniae pneumonia. Am. Rev. Respir. Dis. 125:436–442.PubMedGoogle Scholar
  44. 44.
    Johanson, W.G.Jr, Seidenfeld, J.R., Gomez, P., De Los Santos, R., Coalson, J.J., (1988), Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am. Rev. Respir. Dis. 137:259–264.PubMedGoogle Scholar
  45. 45.
    Rello, J., Paiva, J.A., Baraibor, J., Barcenilla, F., Bodi, M., Castander, D., Correa, H., Diaz, E., Garnacho, J., Llorio, M., Rios, M., Rodriguez, A., Sol-Violan, J., (2001), International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator associated pneumonia. Chest 120:955–970.PubMedGoogle Scholar
  46. 46.
    The Canadian Critical Care Trials Group, (2006), A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N, Engl. J. Med. 335:2619– 2630.Google Scholar
  47. 47.
    Duflo, E., Debon, R., Monneret, G, Bienvenu, J., Chassard, D., Allaouchiche, B., (2002), Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 96:74–79.PubMedGoogle Scholar
  48. 48.
    Brunkhorst, F.M., Al-Nawas, B., Krummenauer, F., Forycki, Z.F., Shah, P.M., (2002), Procalcitonin, C – reactive protein, APACHE II Score for risk evaluation in patients with severe pneumonia. Clin. Microbiol. Infect. 8:93–100.PubMedGoogle Scholar
  49. 49.
    Fukushuma, R., Alexander, J.W., Gianotti, L., Ogle, C.K., (1994), Isolated pulmonary infection acts as a source of systemic tumor necrosis factor. Crit. Care Med. 22:114–120.Google Scholar
  50. 50.
    Wu, C.L., Lee, L.Y., Chang, K.M., King, S.L., Chiang, C.D., Niederman, M.S., (2003), Bronchoalveolar interleukin I β: a marker of bacterial burden in mechanically ventilated paitents with community acquired pneumonia. Crit. Care Med. 31:812–817.PubMedGoogle Scholar
  51. 51.
    Bonten, M.J., Froon, A.H., Gaillard, C.A., Greve, J.W., Drent, M., Stobberingh, E.E., Buur-man, W.A., (1997), The systemic inflammatory response in the development of ventilator associated pneumonia. Am. J. Respir. Crit. Care Med. 156:1105–1113.PubMedGoogle Scholar
  52. 52.
    Bouchon, A., Dietrich, J., Colonna, M., (2000), Inflammatory responses can be triggered by TREM-1, a novel receptor expressed in neutrophils and monocytes. J. Immunol. 164:4991–4995.PubMedGoogle Scholar
  53. 53.
    Bouchon, A., Facchetti, F., Weigand, M.A., Colonna, M., (2001), TREM-1 amplifies inflammation and is a critical mediator of septic shock. Nature 410:1103–1107.PubMedGoogle Scholar
  54. 54.
    Gibot, S., Kolopp-Sarda, M.N., Béné, M.C., Cravoisy, A., Levy, B., Faure, G.C., Bollaert, P. E., (2004), Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann. Intern. Med. 141:9–15.PubMedGoogle Scholar
  55. 55.
    Gibot, S., Cravoisy, A., Levy, B., Beéneé, M.C., Faure, G., Bollaert, P.E., (2004), Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med. 350:451–458.PubMedGoogle Scholar
  56. 56.
    Determann, R.M., Miller, J.L., Gibot, S., Korevaar, J.C., Vroom, M.B., van der Poll, T., Garrard, C.S., Schultz, M.J., (2005), Serial changes in soluble triggering receptor expressed on myeloid cells in the development of ventilator-associated pneumonia. Intern. Care Med. 31:1495–1500.Google Scholar
  57. 57.
    Combes, A., Figliolini, C., Trouillet, J.L., Kasis, N., Wolff, M., Gibert, C., Chastre, J., (2002), Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 121:1390–1391.Google Scholar
  58. 58.
    Dor, P., Robert, R., Grollier, G., Rouffineau, J., Languetot, H., Charries, J.M., Fauchere, J.L., (1996), Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am. J. Respir. Crit. Care Med. 153:1292–1298.Google Scholar
  59. 59.
    Park, D.R., (2005), Microbiology of ventilator-associated pneumonia. Respir. Care 50: 742–763.PubMedGoogle Scholar
  60. 60.
    Woody, A.Y., Davit, A.J. 2nd, Ciraulo, D.L., Arp, N.W., Richart, C.M., Maxwell, R.A., Barker, D.E., (2003), A prospective assessment of diagnostic efficacy of blind protective bronchial brushings compared to bronchoscope assisted lavage, bronchoscope-directed brush-ings, and blind endotracheal aspirates in ventilator-associated pneumonia. J. Trauma-Injury Infect. Crit. Care 55:825–834.Google Scholar
  61. 61.
    Elatrous, S., Boukef, R., Ouanes Besbes, L., Marghli, S., Noonan, S., Nouira, S., Abroug, F., (2004), Diagnosis of ventilator-associated pneumonia: agreement between cultures of endo-tracheal aspiration and plugged telescoping catheter. Intern. Care Med. 30:853–858.Google Scholar
  62. 62.
    Heyland, D.K., Cook, D.J., Marshall, J., Heule, M., Guslits, B., Lang, J., Jaeschke, R., (1999), The clinical utility of invasive diagnostic techniques in the setting of ventilator associated pneumonia. Canadian Critical Care Trial Groups. Chest 115:1076–1084.PubMedGoogle Scholar
  63. 63.
    Fagon, J.Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stephan, F., Similowski, T., Mercat, A., Diehl, J.L., Sollet, J.P., Tenaillon, A., (2000), Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Interm. Med. 132:621–630.Google Scholar
  64. 64.
    Ruiz, M., Torres, Ewig, S., Marcos, M.A., Alcon, A., Lledo, R., Asenjo, M.A., Maldonaldo, A., (2000), Non-invasive versus invasive microbial investigation in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 162:119–125.PubMedGoogle Scholar
  65. 65.
    Ioanas, M., Ferrer, R., Angrill, J., Ferrer, M., Torres, A., (2001), Microbial investigation in ventilator-associated pneumonia. Europ. Respir. 17:791–801.Google Scholar
  66. 66.
    Shorr, A.F., Sherner, J.H., Jackson, W.1., Kollef, M.H., (2005), Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit. Care Med. 33:46–53.PubMedGoogle Scholar
  67. 67.
    Luna, C.M., Vujacich, P., Niederman, M.S., Vay, C., Gherardi, C., Matera, J., Jolly, E.C., (1997), Impact of BAL data on therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685.PubMedGoogle Scholar
  68. 68.
    Ibrahim, E.H., Sherman, G., Ward, S., Fraser, V.J., Kollef, M.H., (2000), The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155.PubMedGoogle Scholar
  69. 69.
    Davis, K.A., Eckert, M.J., Reed, R.L., 2nd, Esposito, T.J., Santaniello, J.M., Poulakidas, S., Luchette, F.A., (2005), Ventilator-associated pneumonia in injured patients: do you trust your Gram's-stain? J. Trauma-Injury Infect. Crit. Care 58:462–466.Google Scholar
  70. 70.
    Laupland, K.B., Church, D.L., Gregson, D.B., (2005), Validation of a rapid diagnostic strategy for determination of significant bacterial counts in bronchoalveolar lavage samples. Arch. Pathol. Lab. Med. 129:78–81.PubMedGoogle Scholar
  71. 71.
    Flanagan, P.G., Jackson, S.K., Findlay, G, (2001), Diagnosis of gram negative, ventilator-associated pneumonia by assaying endotoxin in bronchial lavage fluid. J. Clin. Pathol. 54:107–110.PubMedGoogle Scholar
  72. 72.
    Ibrahim, E.H., Ward, S., Sherman, G., Kollef, M.H., (2000), A comparative analysis of patients with early-onset vs late onset nosocomial pneumonia in the ICU setting. Chest 117:1434–1442.PubMedGoogle Scholar
  73. 73.
    Hayon, J., Figliolini, C., Combes, A., Trouillet, T.L., Kassis, N., Dombret, M.C., Gibert, C., Chastre, J., (2002), Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am, J. Respir. Crit. Care Med. 165:41–46.Google Scholar
  74. 74.
    American Thoracic Society, Infectious Disease Society of America, (2005), ATS/IDSA: guidelines for the management of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388–416Google Scholar
  75. 75.
    National Nosocomial Infection Surveillance, (2004), System report: data summary from January 1992 thorough June 2004, issue October 2004. Am. J. Infect. Control 41:848–854.Google Scholar
  76. 76.
    Beardsley, J.R., Williamson, J.G., Johnson, J.W., Ohl, C.A., Karehmer, TB, Bowton, D.L., (2006), Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonias. Chest 130:787–793.PubMedGoogle Scholar
  77. 77.
    Peterson, D.L., Rice, L.B., (2003), Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect. Dis. 36:1006–1012.Google Scholar
  78. 78.
    Chastre, J., Wolff, M., Fagon, J.Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., Perrin, D., Fieux, F., Aubas, S., (2003), Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598.PubMedGoogle Scholar
  79. 79.
    Singh, N., Rogers, P., Atwood, C.W., Wagener, M.M., Yu, V.L., (2000), Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am. J. Respir. Crit. Care Med. 162: 205–211.Google Scholar
  80. 80.
    Brown, R.B., Kruse, J.A., Counts, G.W., Russell, J.A., Christou, N.V., Sards, M.L, and The Endobronchial Tobramycin Study Group. (1990), Double-blind study of endobronchial tobra-mycin in the treatment of gram-negative bacterial pneumonia. Antimicrob. Agents Cher-mother. 34:269–272.Google Scholar
  81. 81.
    Le Conte, P., Potel, G., Clementi, E., Legras, A., Villars, D., Bironneau, E., Cousson, J., Baron, D., (2000), Administration d'aerosols de tobramycine chez des patients ayant une pnemopathie nosocomiable: etcide preliminaire. RESSE Med. 29:76–78.Google Scholar
  82. 82.
    Munoz-Price, L.S., Weinstein, R.A., (2008), Acinetobacter infection. N. Engl. J. Med. 358: 1271–1281.PubMedGoogle Scholar
  83. 83.
    Carey, R.B., Banerjee, S.N., Srinivasan, A., (2006), Multidrug-resistant acinetobacter infection. 1995–2004. 46th Intersc. Conf. Antimicrob. Agents Chemother, San Francisco Calif. Sept. 27–30, Abstract.Google Scholar
  84. 84.
    Hess, D.R., (2005), Noninvasive positive-pressure ventilation and ventilator-associated pneumonia. Respir. Care; 50:924–929.PubMedGoogle Scholar
  85. 85.
    Sinciff, T., Cook, D.J., (2003), Health technology assessment in the ICU: noninvasive positive pressure ventilation for acute respiratory failure. J. Crit. Care 18:59–67.Google Scholar
  86. 86.
    Antonelli, M., Conti, G., Moro, M.L., Esquinas, A., Gonzalez-Diaz, G., Confalonieri, M., Proietti, R., Passariello, M., Meduri, G.U., (2001), Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxic respiratory failure: a multi-centre study. Intern. Care Med. 27:1718–1728.Google Scholar
  87. 87.
    Hess, D.R., (2005), Patient positioning and ventilator-associated pneumonia. Respir. Care 50:892–898.PubMedGoogle Scholar
  88. 88.
    Choi, S.C., Nelson, LD., (1992), Kinetic therapy in critically ill patients: combined results based on meta-analysis. J. Crit. Care 7:57–62.Google Scholar
  89. 89.
    Collard, H.R., Saint, S., Matthay, M.A., (2003), Prevention of ventilator-associated pneumonia: an evidence-based systemic review. Ann. Intern. Med. 138:494–501.PubMedGoogle Scholar
  90. 90.
    Guerin, C., Gaillard, S., Lemasson, S., Ayzac, L., Girord, R., Beuret, P., Palmier, B., Le, Q.U., Sirodot, M., Rosselli, S., Cadiergue, V., Sainty, J.M., Barbe, P., Combourieu, E.O., Renault, A., Sibille, J.P., Kaidomar, M., (2004), Effects of systematic prone positioning in hypoxic acute respiratory failure: a randomized controlled trial. JAMA 292:2379–2387.PubMedGoogle Scholar
  91. 91.
    Drakulovic, M.B., Torres, A., Bauer, T.T., Nicolas, J.M., Nogue, S., Ferrer, M., (1999), Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 354:1851–1858.PubMedGoogle Scholar
  92. 92.
    Tablan, O.C., Anderson, L.J., Bescer, R., Bridges, C., Hajjeh, R., CDC. Healthcare Infection Control Practices Advisory Committee, (2003), Guidelines for preventing health-care-associated pneumonia: recommendations of CDL and the Healthcare Infection Control Proactive Advisory Committee. M.M.W.R 53:1–36.Google Scholar
  93. 93.
    van Nieuwenhoven, C.A., Vandenbroucke-Grauls, C., van Tiel, F.H., Joone, H.C., van Schijndel, R.J., van der Tweel, I., Ramsay, G., Bonten, M.J., (2006), Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit. Care Med. 34:559–561.Google Scholar
  94. 94.
    Wang, J.Y., Chuang, P.Y., Lin, C.J., Yu, C.J., Yang, P.C., (2003), Continuous latera0l rotational therapy in the medical intensive care unit. J. Formosan Med. Assoc. 102:788–792.PubMedGoogle Scholar
  95. 95.
    Ntoumenopoulos, G., Presneill, J.J., McElholum, M., Code, J.F., (2002), Chest physiotherapy for the prevention of ventilator-associated pneumonia. Intern. Care Med. 28:850–856.Google Scholar
  96. 96.
    Klastersky, J., Huysmans, E., Weerts, D., Hensgens, C., Daneau, D., (1974), Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheotomy: a double blind study. Chest 65:650–654.PubMedGoogle Scholar
  97. 97.
    Libeérati, A., D'Amico, R., Pifferi, Torri, V., Brazzi, L., (2004), Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Systemic Reviews CD000022: PMID 14973945.Google Scholar
  98. 98.
    Bonten, M.J., Kullberg, B.J., van Dalen, R., Girbes, A.R., Hoepelman, I.M., Hustrix, W., van der Meer, J.W., Speelman, P., Stobberingh, E.E., Verbrugh, H.A., Verhoef, J., Zwaveling, J. H., (2000), Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J. Antimicrob. Chemother 43:351–362.Google Scholar
  99. 99.
    Kollef, M.H., (2003), Selective digestive decontamination should not be routinely employed. Chest 123(Suppl. 5):4645–4685.Google Scholar
  100. 100.
    Kallet, R.H., Quinn, T.E., (2005), The gastrointestinal tract and ventilator-associated pneumonia. Respir. Care 50:910–921.PubMedGoogle Scholar
  101. 101.
    Munro, C.L., Grap, M.L., (2004), Oral health and care in the intensive care unit: state of the science. Am. J. Crit. Care 13:25–33.PubMedGoogle Scholar
  102. 102.
    DeRiso, A.J., Jr, Ladowski, J.S., Dillon, T.A., Justice, J.W., Peterson, A.C., (1996), Chlor-hexidine gluconate 0.12% oral rinse reduces the incidence of total nosocominal respiratory infection and nonprophylactic systematic antibiotic use in patients undergoing heart surgery. Chest 109:1556–1561.PubMedGoogle Scholar
  103. 103.
    Houston, S., Hougland, P., Anderson, J.J., LaRocco,M., Kennedy, V., Gentry, L.O., (2002), Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of noso-cominal pneumonia in patients undergoing heart surgery. Am. J. Crit. Care 11:567–570.PubMedGoogle Scholar
  104. 104.
    Genuit, T., Bochicchio, G., Napolitano, L.M., McCarter, R.J., Roghman, M.C., (2001), Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg. Infect. 2:5–18.Google Scholar
  105. 105.
    Fourrier, F., Dubios, D., Pronnier, P., Herberg, P., Leroy, O., Desmettre, T., Potier-Cau, E., Boutigny, H., Di Pompeo, C., Durocher, A., Roussel-Delvallez, M., PIRAD Study Group, (2005), Effect of gingival and dental plague antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicentre study. Crit. Care Med. 33:1867–1868.Google Scholar
  106. 106.
    Tulamait, A., Laghi, F., Mikrut, K., Carey, R.B., Budinger, G.R., (2005), Potassium sorbate reduces gastric colonization in patients receiving mechanical ventilation. J. Crit. Care 20:281–287.PubMedGoogle Scholar
  107. 107.
    Heyland, D.K., Cook, D.J., Schoenfeld, P.S., Frietag, A., Varon, J., Wood, G., (1999), The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicentre randomized trial. Canadian Critical Care Trials Group. Crit. Care Med. 27: 2399–2406.Google Scholar
  108. 108.
    Dezfulian, C., Shojania, K., Collard, H.R., Kim, H.M., Matthay, M.A., Saint, S., (2005), Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analy-sis. Am. J. Med. 118:11–18.PubMedGoogle Scholar
  109. 109.
    Blunt, M.C., Young, P.J., Patil, A., Haddock, A., (2001), Gel lubrication of the tracheal cuff reduces pulmonary aspiration. Anesthesiology 92:377–381.Google Scholar
  110. 110.
    Ibanez, J., Penafiel, A., Morse, P., Jorcla, R., Raurich J.M., Mata, F., (2000), Incidence of gastroesophageal reflux and aspiration in mechanically ventilated patients using small-bore nasogastric trials. J. Parenteral Enteral Nutr. 24:103–106.Google Scholar
  111. 111.
    Kearns, P.J., Chin, D., Mueller, L., Wallace, K., Jensen, W.A., Krisch, C.M., (2000), The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: a randomized clinical trial. Crit. Care Med. 28:1742–1746.PubMedGoogle Scholar
  112. 112.
    Heyland, D.K., Drover, J.W., Dhaliwad, R., Greenwood, J., (2002), Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. J. Parenter. Enteral. Nutr. 26:551–555.Google Scholar
  113. 113.
    Marik, P.E., Zaloga, G.P., (2003), Gastric versus post-pyloric feeding: a systematic review. Crit. Care Med. 7:46–51.Google Scholar
  114. 114.
    Kostadima, E., Kaditis, A.G., Alexopoulos, E.I., Zakynthinos, E., Sfyras, D., (2005), Early gastrostomy reduces the rate of ventilator-associated pneumonia in stroke or head injury patients. Eur. Respir. J. 26:106–111.PubMedGoogle Scholar
  115. 115.
    Kola, A., Eckmanns, T., Gastmeier, P., (2005), Efficacy of heat and moisture exchangers in preventing ventilator-associated pneumonia: meta-analysis of randomized controlled studies. Intern. Care Med. 31:5–11.Google Scholar
  116. 116.
    Combes, P., Fauvage, B., Oleyer, C., (2000), Nosocominal pneumonia in mechanically ventilated patients, a prospective randomized evaluation of the stericath closed suctioning system. Intern. Care Med. 26:878–882.Google Scholar
  117. 117.
    Lorente, L., Lecuona, M., Martin, M.M., Garcia, C., Mora, M.L., Siera, A., (2005), Ventilator-associated pneumonia using closed versus an open tracheal suction system. Crit. Care Med. 33:115–119.PubMedGoogle Scholar
  118. 118.
    Ranes, J.L., Gordon, S.M., Chen, P., Fatica, C. Hammel, J., Gonzales, J.P., Arroliga, A.C., (2006), Predictors of long-term mortality in patients with ventilator-associated pneumonia. Am. J. Med. 119:897.e13–19.PubMedGoogle Scholar
  119. 119.
    Bouza, E., Torres, M.V., Radice, C., Cercenado, E., deDiego, R., Sánchez-Carrillo, C., Munoz, P., (2007), Direct e-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia. Clin. Infect. Dis. 44:382–387.PubMedGoogle Scholar
  120. 120.
    Kollef, M.H., (2007), Moving towards real-time antimicrobial management of ventilator associated pneumonia. Clin. Infect. Dis. 44:388–390.PubMedGoogle Scholar
  121. 121.
    Tenover, F.C., (2007), Rapid detection and identification of bacterial pathogens using novel molecular technologies, Infection control and beyond. Clin. Infect. Dis. 44:418–423.PubMedGoogle Scholar
  122. 122.
    Giamarellos-Bourboulis, EJ, Pechére. J-C, Routsi, C, Plachouras, T, Kollias, S, Raftogiannis, M, Zeruakis, D, Baziaka, F, Koronaios, A, Antonopoulou, A, Markaki, V, Koutoukas, P, Papadomichelakis, E, Tsaganos,T, Armaganidis, A, Koussoulas, V, Kotanidou, A, Roussos, C, Giamarellou, H, (2008), Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin. Infect. Dis. 46:1157–164.PubMedGoogle Scholar
  123. 123.
    Kollef, A.H., Afessa, B., Anzueto, A., Veremakis, C., Kerr, K.M., Margolis, B.D., Craven, D.E., Roberts, P.R., Arroliga, A.C., Hubmayr, R.D., Restrepo, M.I., Auger, W.R., Schinner, R., for the NASCENT Investigation Group, (2008), Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia. JAMA: 300:805–813.PubMedGoogle Scholar
  124. 124.
    Chastre, J., (2008), Preventing ventilator-associtaed pneumonia. Could silver-coated endo-tracheal tube be the answer? JAMA; 300:842–844.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations